Pacific Biosciences of California Inc. (PACB)
NGS · Common · CUSIP 69404D108
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for PACB and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
69404D108
Market Cap
Mid Cap · $710 Million
IPO
10/27/2010 · $16.00/share
Business: Pacific Biosciences' mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research. The Company has developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. Combining recent advances in nanofabrication, biochemistry, molecular biology, surface chemistry and optics, Pacific Biosciences has created a powerful technology platform called single molecule, real-time, or SMRT, technology. SMRT technology enables real-time analysis of biomolecules with single molecule resolution, which has the potential to transform the understanding of biological systems by providing a window into these systems that has not previously been open for scientific study.

Company Contact

CEO
Michael Hunkapiller
CFO
Susan K. Barnes
Headquarters
1305 O’Brien Drive, Menlo Park, CA 94025
Phone
650-521-8000
Investor Relations
650-521-8450 · ir@pacb.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »